These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1378455)

  • 1. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.
    Kronborg G; Fomsgaard A; Galanos C; Freudenberg MA; Høiby N
    J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.
    Kronborg G; Pressler T; Fomsgaard A; Koch C; Høiby N
    Infection; 1993; 21(5):297-302. PubMed ID: 8300245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
    Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR
    J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Fomsgaard A; Høiby N; Shand GH; Conrad RS; Galanos C
    Infect Immun; 1988 Sep; 56(9):2270-8. PubMed ID: 3410536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
    Schiøtz PO; Høiby N; Permin H; Wiik A
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Fomsgaard A; Dinesen B; Shand GH; Pressler T; Høiby N
    J Clin Microbiol; 1989 Jun; 27(6):1222-9. PubMed ID: 2502558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
    Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
    Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.
    Pedersen SS; Espersen F; Høiby N; Jensen T
    J Clin Microbiol; 1990 Apr; 28(4):747-55. PubMed ID: 2110181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.
    Pham A; Ledger EL; Coggon CF; Henderson IR; Reid DW; Bell SC; Smith DJ; Wells TJ
    Infect Immun; 2021 Nov; 89(12):e0041221. PubMed ID: 34460286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis.
    Gaweł J; Pogorzelski A; Działek-Smętek E; Sochań B; Ligarska R; Lącka M; Mazurek H
    Pneumonol Alergol Pol; 2014; 82(4):336-41. PubMed ID: 24964236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
    Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
    J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis.
    Weisner AM; Chart H; Bush A; Davies JC; Pitt TL
    J Med Microbiol; 2007 May; 56(Pt 5):670-674. PubMed ID: 17446292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in serum and sputum from patients with cystic fibrosis.
    Schiøtz PO; Egeskjold EM; Høiby N; Permin H
    Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of immunologic factors in cystic fibrosis.
    Przyklenk B; Bauernfeind A
    Scand J Gastroenterol Suppl; 1988; 143():103-9. PubMed ID: 2455329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.
    Brauner A; Cryz SJ; Granström M; Hanson HS; Löfstrand L; Strandvik B; Wretlind B
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):430-6. PubMed ID: 8359163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
    Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
    Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis.
    Pedersen SS; Møller H; Espersen F; Sørensen CH; Jensen T; Høiby N
    APMIS; 1992 Apr; 100(4):326-34. PubMed ID: 1581041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.